Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 12.39
-1.04 %
$ 1.13 B
Market Cap
-9.68
P/E
MYGN - COMMON STOCK REPURCHASED
Common Stock Repurchased MYGN - Myriad Genetics, Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
14.87%
5 YEAR CAGR
7.18%
10 YEAR CAGR